Baker Bros. Advisors LP 13D and 13G filings for Entrada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-06-26 4:54 pm Purchase |
2024-06-24 | 13D | Entrada Therapeutics, Inc. TRDA |
Baker Bros. Advisors LP | 4,865,819 13.200% |
161,400 (+3.43%) |
Filing |
| 2021-12-16 5:23 pm Unchanged |
2021-12-14 | 13D | Entrada Therapeutics, Inc. TRDA |
Baker Bros. Advisors LP | 4,704,419 15.100% |
0 (Unchanged) |
Filing |
| 2021-11-10 4:50 pm Purchase |
2021-11-02 | 13G | Entrada Therapeutics, Inc. TRDA |
Baker Bros. Advisors LP | 4,704,419 15.100% |
4,704,419 (New Position) |
Filing |